Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Ebert

Showing results (181-190 of 339) with videos related to

Pageof 34
Sort By:
Nature Chemistry|December 18, 2023
Proteolysis-targeting chimeras with reduced off-targetsTuan M Nguyen, Vedagopuram Sreekanth, Arghya Deb, et al.
Blood Advances|August 3, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapyPeter G Miller, Adam S Sperling, Elliott J Brea, et al.
Blood|October 12, 2017
<i>SETD2</i> alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemiaBrenton G Mar, S Haihua Chu, Josephine D Kahn, et al.
Journal of the American Chemical Society|September 28, 2023
Chemical Specification of E3 Ubiquitin Ligase Engagement by Cysteine-Reactive ChemistryRoman C Sarott, Inchul You, Yen-Der Li, et al.
Blood Cancer Journal|January 12, 2022
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)Warren Fiskus, Steffen Boettcher, Naval Daver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2014
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantationRafael Bejar, Kristen E Stevenson, Bennett Caughey, et al.
Blood|June 30, 2018
<i>PPM1D</i>-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cellsJosephine D Kahn, Peter G Miller, Alexander J Silver, et al.
Plos Medicine|July 13, 2006
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasiaYana Pikman, Benjamin H Lee, Thomas Mercher, et al.
Blood|August 15, 2013
Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndromeAdrianna Vlachos, Jason E Farrar, Eva Atsidaftos, et al.
The Journal of Clinical Investigation|February 16, 2016
MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1CNan Zhu, Mo Chen, Rowena Eng, et al.
Pageof 34

Showing results (181-190 of 339) with videos related to

Sort By:
Pageof 34
Nature Chemistry|December 18, 2023
Proteolysis-targeting chimeras with reduced off-targetsTuan M Nguyen, Vedagopuram Sreekanth, Arghya Deb, et al.
Blood Advances|August 3, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapyPeter G Miller, Adam S Sperling, Elliott J Brea, et al.
Blood|October 12, 2017
<i>SETD2</i> alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemiaBrenton G Mar, S Haihua Chu, Josephine D Kahn, et al.
Journal of the American Chemical Society|September 28, 2023
Chemical Specification of E3 Ubiquitin Ligase Engagement by Cysteine-Reactive ChemistryRoman C Sarott, Inchul You, Yen-Der Li, et al.
Blood Cancer Journal|January 12, 2022
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)Warren Fiskus, Steffen Boettcher, Naval Daver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 6, 2014
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantationRafael Bejar, Kristen E Stevenson, Bennett Caughey, et al.
Blood|June 30, 2018
<i>PPM1D</i>-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cellsJosephine D Kahn, Peter G Miller, Alexander J Silver, et al.
Plos Medicine|July 13, 2006
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasiaYana Pikman, Benjamin H Lee, Thomas Mercher, et al.
Blood|August 15, 2013
Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q- syndromeAdrianna Vlachos, Jason E Farrar, Eva Atsidaftos, et al.
The Journal of Clinical Investigation|February 16, 2016
MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1CNan Zhu, Mo Chen, Rowena Eng, et al.
Pageof 34